查詢結果分析
來源資料
相關文獻
- 以化學治療藥物Epirubicin治療血液惡性疾病之臨床報告
- 食道之旅--由咽至胃的疾病與健康
- High Dose Chemotherapy with Peripheral Blood Stem Cells Transplantation in Patients with Relapsed or Refractory Lymphomas-Preliminary Reports
- 臺北地區感染心絲蟲犬隻之血液生化學變化
- 血液惡性疾病之體外化學藥物敏感試驗
- 干擾素治療惡性血液疾病的現況與展望
- Propranolol 中毒:報告臨床症狀及藥物治療結果相異之兩病例
- 用ACG風險校正系統篩選臺灣地區高風險血液透析治療病人
- 藥物動力學在臨床上之應用:藥物動力學服務
- 藥師對門診哮喘病患之照顧成效:案例報告
頁籤選單縮合
| 題 名 | 以化學治療藥物Epirubicin治療血液惡性疾病之臨床報告 |
|---|---|
| 作 者 | 黃偉修; | 書刊名 | 醫學研究 |
| 卷 期 | 8:1 1987.07[民76.07] |
| 頁 次 | 頁35-39 |
| 分類號 | 415.656 |
| 關鍵詞 | 化學; 血液; 治療; 疾病; 報告; 惡性; 臨床; 藥物治療; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 化學治療藥物Epirubicin是一種與Doxorubicin(Adriamycin)功能相似但結構不同的藥物,經動物及人類臨床試驗證實具有高度的抗癌療效。在治療血液惡性疾病7例患者中,我們以Epirubicin結合其他化學藥物給予治療。其中有5例獲得完全緩解,2例獲得部分緩解,僅有1例對此化學治療無效。其主要之副作用為禿髮、骨髓抑制作用及輕微的嘔吐,治療的7例患者中沒有產生心臟毒性之副作用。 |
| 英文摘要 | Epirubicin is a doxorubicin analogue presenting a high degree of activity against experimental animal tumors as well as human tumors. We conducted a clinical trial of epirubicin in treating patients with hematological malignancy. Five patients with Non-Hodgkin’s lymphoma were treated by CEVP. One patient of relapsed Hodgkin’s disease was treated by EBV. One patient with relapsed ALL was treated by EVP. Five of the 7 patients had complete remission (71.4%) after treatment. Two patients had partial remission. One patient had no response to treatment at all. The major side effects were alopesia, bone marrow suppression and mild degree of vomiting. No cardiac toxicity was found in any case. |
本系統中英文摘要資訊取自各篇刊載內容。